nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PPARG—brown adipose tissue—adrenal gland cancer	0.142	0.217	CbGeAlD
Rosiglitazone—CYP2C19—urine—adrenal gland cancer	0.0678	0.104	CbGeAlD
Rosiglitazone—CYP1A2—urine—adrenal gland cancer	0.0554	0.0847	CbGeAlD
Rosiglitazone—ACSL4—adrenal cortex—adrenal gland cancer	0.0529	0.0808	CbGeAlD
Rosiglitazone—CYP2C9—urine—adrenal gland cancer	0.0526	0.0804	CbGeAlD
Rosiglitazone—ACSL4—gonad—adrenal gland cancer	0.0438	0.0669	CbGeAlD
Rosiglitazone—ACSL4—cardiac atrium—adrenal gland cancer	0.0437	0.0668	CbGeAlD
Rosiglitazone—ACSL4—pituitary gland—adrenal gland cancer	0.0427	0.0653	CbGeAlD
Rosiglitazone—CYP2D6—urine—adrenal gland cancer	0.0394	0.0603	CbGeAlD
Rosiglitazone—ACSL4—adrenal gland—adrenal gland cancer	0.0382	0.0583	CbGeAlD
Rosiglitazone—PPARG—Nuclear Receptors—NR5A1—adrenal gland cancer	0.0192	0.0554	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.0183	0.0529	CbGpPWpGaD
Rosiglitazone—PPARG—adrenal gland—adrenal gland cancer	0.0172	0.0262	CbGeAlD
Rosiglitazone—ALB—adrenal gland—adrenal gland cancer	0.0161	0.0246	CbGeAlD
Rosiglitazone—PPARG—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.0151	0.0438	CbGpPWpGaD
Rosiglitazone—CYP2C8—pituitary gland—adrenal gland cancer	0.0127	0.0194	CbGeAlD
Rosiglitazone—CYP2A6—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.0115	0.0331	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.011	0.0318	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.0108	0.0313	CbGpPWpGaD
Rosiglitazone—PTGS1—cardiac atrium—adrenal gland cancer	0.0105	0.0161	CbGeAlD
Rosiglitazone—PTGS1—pituitary gland—adrenal gland cancer	0.0103	0.0157	CbGeAlD
Rosiglitazone—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.01	0.029	CbGpPWpGaD
Rosiglitazone—PTGS1—adrenal gland—adrenal gland cancer	0.00918	0.014	CbGeAlD
Rosiglitazone—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00863	0.025	CbGpPWpGaD
Rosiglitazone—PPARG—Noncanonical Wnt signaling pathway—CDC42—adrenal gland cancer	0.00818	0.0236	CbGpPWpGaD
Rosiglitazone—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.0073	0.0211	CbGpPWpGaD
Rosiglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—MED12—adrenal gland cancer	0.00655	0.0189	CbGpPWpGaD
Rosiglitazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—adrenal gland cancer	0.00569	0.0165	CbGpPWpGaD
Rosiglitazone—PPARG—SREBP signalling—PRKACA—adrenal gland cancer	0.00521	0.0151	CbGpPWpGaD
Rosiglitazone—PPARG—Signaling events mediated by HDAC Class I—PRKACA—adrenal gland cancer	0.00515	0.0149	CbGpPWpGaD
Rosiglitazone—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00508	0.0147	CbGpPWpGaD
Rosiglitazone—PPARG—PPARA activates gene expression—MED12—adrenal gland cancer	0.00492	0.0142	CbGpPWpGaD
Rosiglitazone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—adrenal gland cancer	0.00484	0.014	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.00482	0.0139	CbGpPWpGaD
Rosiglitazone—PTGS1—Overview of nanoparticle effects—PTGS2—adrenal gland cancer	0.00446	0.0129	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00431	0.0125	CbGpPWpGaD
Rosiglitazone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—adrenal gland cancer	0.00421	0.0122	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—SDHB—adrenal gland cancer	0.00399	0.0115	CbGpPWpGaD
Rosiglitazone—PTGS1—Eicosanoid Synthesis—PTGS2—adrenal gland cancer	0.0037	0.0107	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.00332	0.00959	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00314	0.00908	CbGpPWpGaD
Rosiglitazone—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.0031	0.00895	CbGpPWpGaD
Rosiglitazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.00309	0.00895	CbGpPWpGaD
Rosiglitazone—ALB—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	0.00303	0.00877	CbGpPWpGaD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—adrenal gland cancer	0.00294	0.00849	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—RB1—adrenal gland cancer	0.00286	0.00827	CbGpPWpGaD
Rosiglitazone—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00282	0.00816	CbGpPWpGaD
Rosiglitazone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00269	0.00778	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.00262	0.00756	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—RRM1—adrenal gland cancer	0.00257	0.00744	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—SDHD—adrenal gland cancer	0.00257	0.00744	CbGpPWpGaD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—adrenal gland cancer	0.00255	0.00736	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00252	0.00728	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—CDKN2A—adrenal gland cancer	0.00251	0.00727	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—SPARC—adrenal gland cancer	0.00247	0.00714	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—NR5A1—adrenal gland cancer	0.00246	0.00712	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	0.00235	0.0068	CbGpPWpGaD
Rosiglitazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.0023	0.00665	CbGpPWpGaD
Rosiglitazone—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00211	0.00609	CbGpPWpGaD
Rosiglitazone—PTGS1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00206	0.00595	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—MED12—adrenal gland cancer	0.00192	0.00554	CbGpPWpGaD
Rosiglitazone—PTGS1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00181	0.00522	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00171	0.00496	CbGpPWpGaD
Rosiglitazone—CYP2A6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00171	0.00494	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—IGF2—adrenal gland cancer	0.0017	0.00493	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—RB1—adrenal gland cancer	0.00166	0.00481	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	0.00162	0.00469	CbGpPWpGaD
Rosiglitazone—CYP2A6—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00161	0.00467	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—MED12—adrenal gland cancer	0.00157	0.00455	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.0015	0.00434	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MED12—adrenal gland cancer	0.00148	0.00428	CbGpPWpGaD
Rosiglitazone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00144	0.00416	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PRKACA—adrenal gland cancer	0.0014	0.00404	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00137	0.00395	CbGpPWpGaD
Rosiglitazone—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00133	0.00384	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00132	0.00382	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00131	0.00378	CbGpPWpGaD
Rosiglitazone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00128	0.00372	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—NR5A1—adrenal gland cancer	0.00126	0.00364	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—SDHB—adrenal gland cancer	0.00122	0.00354	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—CTNNB1—adrenal gland cancer	0.00122	0.00354	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.0012	0.00347	CbGpPWpGaD
Rosiglitazone—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00119	0.00343	CbGpPWpGaD
Rosiglitazone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00118	0.00342	CbGpPWpGaD
Rosiglitazone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00117	0.00339	CbGpPWpGaD
Rosiglitazone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00117	0.00337	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—GNAS—adrenal gland cancer	0.00113	0.00328	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ABCB1—adrenal gland cancer	0.00111	0.00322	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00109	0.00317	CbGpPWpGaD
Rosiglitazone—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00108	0.00313	CbGpPWpGaD
Rosiglitazone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00104	0.00301	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00104	0.00301	CbGpPWpGaD
Rosiglitazone—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.001	0.00289	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.000988	0.00286	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—SDHB—adrenal gland cancer	0.000965	0.00279	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000964	0.00279	CbGpPWpGaD
Rosiglitazone—PTGS1—Biological oxidations—POMC—adrenal gland cancer	0.00096	0.00277	CbGpPWpGaD
Rosiglitazone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000958	0.00277	CbGpPWpGaD
Rosiglitazone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00095	0.00275	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000926	0.00268	CbGpPWpGaD
Rosiglitazone—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000924	0.00267	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—CDC42—adrenal gland cancer	0.000916	0.00265	CbGpPWpGaD
Rosiglitazone—CYP2A6—Biological oxidations—POMC—adrenal gland cancer	0.000908	0.00262	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SDHB—adrenal gland cancer	0.000858	0.00248	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00084	0.00243	CbGpPWpGaD
Rosiglitazone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000812	0.00235	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SDHB—adrenal gland cancer	0.000811	0.00235	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—RRM1—adrenal gland cancer	0.000789	0.00228	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—SDHD—adrenal gland cancer	0.000789	0.00228	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.000784	0.00227	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—POMC—adrenal gland cancer	0.000763	0.00221	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000759	0.00219	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MED12—adrenal gland cancer	0.000757	0.00219	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000756	0.00218	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MEN1—adrenal gland cancer	0.000723	0.00209	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000722	0.00209	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.0007	0.00202	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.0007	0.00202	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000675	0.00195	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—TP53—adrenal gland cancer	0.00063	0.00182	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—RRM1—adrenal gland cancer	0.000622	0.0018	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—SDHD—adrenal gland cancer	0.000622	0.0018	CbGpPWpGaD
Rosiglitazone—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	0.00062	0.00179	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—PTGS2—adrenal gland cancer	0.000609	0.00176	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000598	0.00173	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000595	0.00172	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—MED12—adrenal gland cancer	0.000589	0.0017	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000585	0.00169	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—TP53—adrenal gland cancer	0.000574	0.00166	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000574	0.00166	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SPARC—adrenal gland cancer	0.000564	0.00163	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SDHB—adrenal gland cancer	0.000554	0.0016	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000553	0.0016	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—SDHD—adrenal gland cancer	0.000553	0.0016	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—RRM1—adrenal gland cancer	0.000553	0.0016	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SDHB—adrenal gland cancer	0.000551	0.00159	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000534	0.00154	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000526	0.00152	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—RRM1—adrenal gland cancer	0.000523	0.00151	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—SDHD—adrenal gland cancer	0.000523	0.00151	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000509	0.00147	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000505	0.00146	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000495	0.00143	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000487	0.00141	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PRKACA—adrenal gland cancer	0.000476	0.00138	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—MED12—adrenal gland cancer	0.000463	0.00134	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000455	0.00132	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000451	0.0013	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000436	0.00126	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000434	0.00125	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	0.000431	0.00125	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PRKACA—adrenal gland cancer	0.000429	0.00124	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—CTNNB1—adrenal gland cancer	0.00042	0.00122	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00042	0.00121	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000416	0.0012	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000414	0.0012	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000412	0.00119	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—MED12—adrenal gland cancer	0.000412	0.00119	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—CDC42—adrenal gland cancer	0.000404	0.00117	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—MED12—adrenal gland cancer	0.00039	0.00113	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—IGF2—adrenal gland cancer	0.000389	0.00113	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000389	0.00113	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—GNAS—adrenal gland cancer	0.000386	0.00112	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SDHB—adrenal gland cancer	0.000385	0.00111	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000369	0.00107	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—SDHD—adrenal gland cancer	0.000357	0.00103	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—RRM1—adrenal gland cancer	0.000357	0.00103	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—RRM1—adrenal gland cancer	0.000355	0.00103	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—SDHD—adrenal gland cancer	0.000355	0.00103	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000355	0.00103	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GNAS—adrenal gland cancer	0.000348	0.00101	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ABCB1—adrenal gland cancer	0.000341	0.000987	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PRKACA—adrenal gland cancer	0.000338	0.000978	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000334	0.000966	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—EGFR—adrenal gland cancer	0.000333	0.000963	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00033	0.000955	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000328	0.000948	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000319	0.000922	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000319	0.000922	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000303	0.000877	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PRKACA—adrenal gland cancer	0.000301	0.00087	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000294	0.00085	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000293	0.000848	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000293	0.000848	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000291	0.00084	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000291	0.00084	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	0.000284	0.000822	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GNAS—adrenal gland cancer	0.000274	0.000792	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ABCB1—adrenal gland cancer	0.000269	0.000777	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MED12—adrenal gland cancer	0.000266	0.00077	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MED12—adrenal gland cancer	0.000265	0.000766	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—RRM1—adrenal gland cancer	0.000248	0.000718	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SDHD—adrenal gland cancer	0.000248	0.000718	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GNAS—adrenal gland cancer	0.000244	0.000705	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ABCB1—adrenal gland cancer	0.000239	0.000692	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000238	0.000688	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000238	0.000687	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000237	0.000684	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—POMC—adrenal gland cancer	0.000234	0.000677	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GNAS—adrenal gland cancer	0.000231	0.000666	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	0.000226	0.000654	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000219	0.000632	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000217	0.000627	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000212	0.000614	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	0.000194	0.000562	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000194	0.00056	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PRKACA—adrenal gland cancer	0.000193	0.000559	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00019	0.000549	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000189	0.000546	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—adrenal gland cancer	0.000187	0.00054	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MED12—adrenal gland cancer	0.000185	0.000535	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—POMC—adrenal gland cancer	0.000184	0.000533	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.000173	0.000501	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000169	0.00049	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000166	0.000479	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—POMC—adrenal gland cancer	0.000164	0.000475	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000159	0.000461	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000158	0.000457	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GNAS—adrenal gland cancer	0.000157	0.000455	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GNAS—adrenal gland cancer	0.000157	0.000453	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—POMC—adrenal gland cancer	0.000155	0.000449	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000155	0.000447	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	0.000155	0.000447	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCB1—adrenal gland cancer	0.000154	0.000444	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—adrenal gland cancer	0.000147	0.000425	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000141	0.000406	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000138	0.000399	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	0.000135	0.000391	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000132	0.000382	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—adrenal gland cancer	0.000131	0.000379	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000129	0.000374	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000128	0.000371	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000127	0.000367	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000126	0.000364	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	0.000124	0.000358	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—adrenal gland cancer	0.000123	0.000357	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GNAS—adrenal gland cancer	0.00011	0.000317	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	0.000107	0.000311	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—POMC—adrenal gland cancer	0.000106	0.000307	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—POMC—adrenal gland cancer	0.000105	0.000305	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—POMC—adrenal gland cancer	9.46e-05	0.000274	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—POMC—adrenal gland cancer	8.7e-05	0.000252	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—POMC—adrenal gland cancer	8.63e-05	0.000249	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	8.46e-05	0.000244	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—adrenal gland cancer	8.41e-05	0.000243	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	7.55e-05	0.000218	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—POMC—adrenal gland cancer	7.37e-05	0.000213	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	6.94e-05	0.000201	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	6.88e-05	0.000199	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	5.88e-05	0.00017	CbGpPWpGaD
